Imedex: Education is the Best Medicine®

QUICK POLL

What percentage of new treatments tested in NCI-funded phase III randomized controlled trials from 1995 to 2000 were successful compared to standard treatment?

Announcements

NEW FRONTIERS IN MYELOMA MANAGEMENT WEBCAST

This Webcast provides an overview of the current and future treatment strategies for the following scenarios: 1) induction therapy for the patient who is transplant eligible; 2) induction for transplant ineligible patients; 3) relapsed or refractory disease; 4) maintenance of remission. There is also a discussion of future directions for patients with multiple myeloma...

View activity

GREAT DEBATES AND UPDATES IN HEMATOLOGY

Great Debates & Updates in Hematology will cover the broad continuum of hematologic malignancies, from lymphoma to leukemia to myeloma to myeloproliferative disorders, in order to have the broadest appeal to attendees and to provide the most substantial curriculum.

Learn more

A FRESH APPROACH TO CME

From genetics to the management of advanced disease, from screening to surgery and supportive care, from the optimal use of standard therapies to expert perspectives on emerging agents, the full spectrum of clinical management will be addressed at the 9th Perspectives in Colorectal Cancer. September 19-20 in Miami.